[Studies on anti-inflammatory agents. VI. Absorption, Excretion and metabolism of 2-amino-3-ethoxycarbonyl-6-benzyl(alpha-14C)-4,5,6,7-tetrahydrothieno(2,3-c)pyridine (14C-Y-3642) in mice].
D000284:Administration, Oral; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism* / Q000652:urine; D002247:Carbon Isotopes; D002855:Chromatography, Thin Layer; D006626:Hippurates / Q000378:metabolism; D007274:Injections, Intraperitoneal; D007408:Intestinal Absorption; D008297:Male; D051379:Mice; D010636:Phenols / Q000378:metabolism; D011725:Pyridines / Q000378:metabolism* / Q000652:urine; D013876:Thiophenes / Q000378:metabolism / Q000652:urine
D000893:Anti-Inflammatory Agents; D002247:Carbon Isotopes; D006626:Hippurates; D010636:Phenols; D011725:Pyridines; D013876:Thiophenes